Fig. 2From: The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancerKaplan-Meier survival curves of a progression-free survival (PFS) and b overall survival (OS) of the 65 enrolled patients stratified by the Eastern Cooperative Oncology Group (ECOG) performance status scores (log-rank test of ECOG 0 vs 1 vs 2)Back to article page